I-PEN® Osmolarity System
Federal Court of Appeal Upholds I-MED Pharma’s Patent Win Against TearLab
17 juin 2019 11h05 HE | I-MED Pharma
MONTREAL, June 17, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today that the Canadian Federal Court of Appeal...
I-MED Pharma Becomes the Authorized Canadian Distributor for the OrCam MyEye 2
10 avr. 2019 11h11 HE | I-MED Pharma
MONTREAL, April 10, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management is proud to announce the signing of an authorized Canadian...
I-MED Pharma celebrates its 30th Anniversary!
I-MED Pharma Celebrates 30 Years of Providing OSD & Surgical Solutions to the Global Eye Care Community
01 avr. 2019 10h22 HE | I-MED Pharma
MONTREAL, April 01, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, proudly announces its 30-year anniversary providing OSD &...
I-PEN® Osmolarity System
I-PEN® Osmolarity System Now Available in Brazil Through Partnership with DryCom
26 mars 2019 13h42 HE | I-MED Pharma
MONTREAL, March 26, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management, announced today the signing of an exclusive agreement with...
Iogen PR image
I-MED Pharma Partners with Iogen Oy to Introduce I-DROP®, I-LID ’N LASH®, I-RELIEF™ Therapeutic Eye Mask and the I-PEN® Osmolarity System to the Finnish Market
01 nov. 2018 10h35 HE | I-MED Pharma
MONTREAL, Nov. 01, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive distribution...
quidel PR image
I-MED Pharma Partners with Quidel to Introduce I-LID ’N LASH®, I-RELIEF® and SMTube® to the U.S Market
17 oct. 2018 11h18 HE | I-MED Pharma
MONTREAL, Oct. 17, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive distribution...
I-PEN® Tear Osmolarity System
I-MED Pharma Partners with Simovision to Bring the I-PEN® Osmolarity System to Belgium, Luxembourg & the Netherlands
02 oct. 2018 10h54 HE | I-MED Pharma
MONTREAL, Oct. 02, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive agreement with...
i-Pen_angle1-withshadow
I-MED Pharma Inc. Announces Partnership with Medicals International
23 juil. 2018 11h41 HE | I-MED Pharma
MONTREAL, July 23, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive agreement with...
I-MED Pharma présente la technologie éprouvée E>Eye IRPL® au Canada
24 mai 2018 13h36 HE | I-MED Pharma
MONTRÉAL, 24 mai 2018 (GLOBE NEWSWIRE) -- I-MED Pharma inc., une entreprise canadienne spécialisée dans le diagnostic et la prise en charge de la sécheresse oculaire, est ravie d’annoncer...
E-EYE in use
I-MED Pharma to Bring Clinically Proven E>Eye IRPL® Technology to Canada
24 mai 2018 13h36 HE | I-MED Pharma
MONTREAL, May 24, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of a Canadian distribution...